Aaron Anselmo

@Aaron_Anselmo

Assistant Professor, Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC Chapel Hill

Vrijeme pridruživanja: rujan 2013.

Tweetovi

Blokirali ste korisnika/cu @Aaron_Anselmo

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Aaron_Anselmo

  1. proslijedio/la je Tweet
    Poništi
  2. proslijedio/la je Tweet
    3. velj

    Our update on translation of glucose-responsive smart insulin patch with pig study.

    Poništi
  3. proslijedio/la je Tweet
    1. velj

    Amazing recruits and hosts well! We are so lucky to have such an amazing group of recruits and current students from , & our labs.

    Poništi
  4. proslijedio/la je Tweet
    28. sij 2019.

    Looking for a post-doc!! Preferred experience: Hemostasis/Thrombosis/Thromboinflammation; Cell Signaling and Biochemical Assays; Animal Models; Medicinal Chemistry; strong interest in technology/pharmaceutics translation is highly preferred. Please RT!! E-mail: axs262@case.edu

    Poništi
  5. proslijedio/la je Tweet
    24. sij

    We are hiring! pls RT. Looking for post docs to develop a universal flu vaccine on a NIH funded project. Skills that are a must: immune cell isolation, ELISA/ELISpot, & flow. Skills with virus a plus! Must have out or planned at least 1 1st author pub.

    Poništi
  6. proslijedio/la je Tweet

    Only 15 days left to submit your abstract to before submissions close on January 31st! We can't wait to

    Poništi
  7. proslijedio/la je Tweet

    We’ve got the perfect way to kick off your 2020: Abstract submission are now OPEN for the International Conference! Submit yours by January 31st - we can’t wait to

    Poništi
  8. proslijedio/la je Tweet
    17. pro 2019.
    Poništi
  9. proslijedio/la je Tweet
    12. pro 2019.

    's Aaron Anselmo and Leaf Huang are advancing medicine for life. Check out their recently published work in , discussing the use of nanotechnology intervention of the microbiome for cancer therapy.

    Poništi
  10. 11. pro 2019.

    Looking to recruit a postdoc on projects related to living biological therapeutic (microbes) delivery or nanotechnology for microbiome modulation. If interested, please send me a direct message or email.

    Poništi
  11. proslijedio/la je Tweet

    New content online: Nanotechnology intervention of the microbiome for cancer therapy

    Poništi
  12. 4. pro 2019.
    Poništi
  13. proslijedio/la je Tweet
    25. stu 2019.

    Researchers have developed a biocompatible polymer coating that prevents micronutrients from degrading due to heat or storage. If effective in larger clinical trials, this strategy could help combat nutritional deficiencies.

    Poništi
  14. proslijedio/la je Tweet
    20. stu 2019.

    Looking forward to speaking and running the Power Hour Drug Carriers in Medicine & Biology! ty &

    Poništi
  15. proslijedio/la je Tweet

    Apply to our PhD program by Dec 1 for best consideration. Join us to work with our outstanding faculty and students!

    Poništi
  16. proslijedio/la je Tweet
    17. stu 2019.

    Loving the opening lecture by Samir on RBCs for tumor targeting. Congratulations for hosting the largest ever Drug Delivery Australia meeting over 180 attendees! So many colleagues and friends here! +..

    Poništi
  17. 14. stu 2019.

    Huge effort that required extensive collaboration and working with many experts in different areas

    Prikaži ovu nit
    Poništi
  18. 14. stu 2019.

    Finally out! Paper has it all from in vitro to in vivo to human clinical trials to process design for scale up at the kg-scale!

    Prikaži ovu nit
    Poništi
  19. 13. stu 2019.
    Poništi
  20. proslijedio/la je Tweet
    12. stu 2019.

    Thanks to ⁦⁦⁩ & the talented ⁦⁩ for highlighting our work on silica nanoparticle oral permeation enhancers in this week’s issue. Plus to ⁦⁩ for not trashing the paper when he was called on for comment. 😆

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·